Mr. Galanaugh has had a wide variety of functional and managerial roles, which include product development engineering, marketing and sales management, division general management, corporate business development, newsletter editing and independent consulting. After several years of aerospace engineering he joined Becton Dickinson and Company. At BD, he was responsible for new product development /market introduction for many very successful analytical systems products, for various clinical laboratory sites, such as hospitals, commercial and physician’s office laboratories. He has managed both direct sales forces and distribution relationship efforts.
He served as President of Becton Dickinson, Primary Care Division and as Corporate Vice President of Business Development for the Diagnostic Sector. In recent years, his consultation efforts focused on "the strategic implications of technology innovation". He has developed processes for assessing opportunity, evaluating technology and specifying the requirements for commercial success. His experience is relevant to the interpretation of both customer preference and technology promise. Most of his efforts have been focused on worldwide healthcare issues and on products subject to FDA regulation.
In addition, he has served as President of NCCLS (now, CLSI), the global organization responsible for voluntary consensus standards for clinical laboratory practice. He currently serves as a member of the Board of Trustees of the Van Slyke Foundation, a not-for-profit entity of the American Association for Clinical Chemistry, devoted to supporting programs in education, research and career development.
Mr. Galanaugh received a Bachelor of Mechanical Engineering from Polytechnic University (Brooklyn, NY) and a Master of Business Administration from Seton Hall University (South Orange, NJ).
Joy Parr Drach is President of Advanced Animal Diagnostics and brings a unique combination of agribusiness and new product introduction expertise to the company. She was a founder and senior partner of Entira, a management and marketing consulting firm for agribusiness companies, where she led strategic planning programs and implemented management and marketing programs with clients ranging from small start-ups to Fortune 100 industry leaders. She has successfully launched more than 30 new products ranging from U.S. dairy parlors to global herbicides and spray equipment, including product development, pricing strategies, distribution plans, sales training and marketing/promotion planning and execution.
Parr Drach is also actively involved in her family’s grain and purebred livestock operation. She earned a bachelor of science in Agricultural Communications from the University of Illinois, and a Master of Business Administration from the University of Chicago.
Rudy Rodriguez is the Chief Scientific Officer of Advanced Animal Diagnostics. He has a Master's Degree in Biomedical Engineering from George Washington University and holds the Professional Engineer (PE) certification. He has thirty years experience in development of diagnostic instrumentation, twenty-eight patents and is a four-time winner of the R & D 100 Award as one of the 100 most significant new technical products of the year. He served as the Vice President of Research & Development for Becton Dickinson's Primary Care Diagnostics Division for fifteen years. Prior to that, he was an R & D executive for Coulter (now Beckman-Coulter) and Baxter International diagnostic divisions. He was the Project Leader of the world's most successful Physician Office Hematology (BD's QBC and QBC Autoread ), and the Project Leader in the world's most successful Veterinary Office Hematology System (marketed by Idexx as Autoread). He participated in the development of the NCCLS H20 Standard used for evaluation of automated leukocyte differential instruments. He is a co-inventor and was the BD Project Leader of the R & D team that developed the base technology upon which AAD was founded. Rodriguez is also an adjunct professor at North Carolina State University.
Mr. Linn most recently served as Alliance Manager, Business Development, BD Technologies, in Research Triangle Park. In recent years, among other duties, he managed the BD Technologies Incubator and was involved with 15 emerging companies in the area. These companies have created over 500 jobs and raised almost $500 million dollars in VC Funding, Grants, or Corporate Funding. Before his 22 years at BD, he was a researcher at Research Triangle Institute and Union Carbide Ag Products. Mr. Linn has 21 Publications and 15 issued US Patents, including several in a successful molecular diagnostic product commercialized by BD. He graduated from UNC at Chapel Hill with a BS in Chemistry. He is the member of several professional societies including, American Chemical Society (ACS), American Society for Microbiology (ASM), and Licensing Executives Society (LES).
Deborah Asion began her work as a Scientist for AAD in August 2004. She brings 15 years of laboratory experience to AAD with special emphasis on cytology and hematology. She also has a strong research and development background that includes experience in flow and image cytometry, chemistry, immunology, microbiology and blood bank. Ms. Asion is an ASCP certified Medical technologist and has received accreditation from the American Society for Clinical Laboratory Science in Molecular Biology.
Prior to joining AAD, she was with Dade Behring in Newark, Delaware as a Compliance Analyst and as a R&D Assistant Chemist working in the Cardiac QC Division. She has also worked for Battelle Memorial Institute, Columbus Ohio, as a Cell Image Consultant on a project regarding the identification of Fluorescent Cellular Images and at Becton Dickinson as a Research Associate on Fluorescent Microscopic Imaging and Analysis and Bovine Hematology including research on Mastitis.
Ms. Asion holds a Bachelor of Science degree in Marine Biology from Long Island University, and has completed several graduate level courses at Clemson University in Biochemistry.
Mr. Greenbaum is the former president of Greenbaum and Orecchio, Inc., a wealth management firm that provided investment advisory services to 225 clients in 21 states. He founded the firm in 1982 and sold his shares to his three partners in 2008 after 26 years in the business. Greenbaum was named one of the top 100 Wealth Advisors in the nation by Worth Magazine in 2007 and a Reuters AdvisePoint Top Advisor in 2008. In addition, Greenbaum and Orecchio, Inc. has been named one of the leading wealth management firms in the nation for the last eight consecutive years by Wealth Manager Magazine.
Greenbaum has served in leadership and board positions for a number of industry and professional organizations, including National Association of Personal Financial Advisors, Investment Management Consultants Association, the CFA Institute, and the New York Society of Securities Analysts, among others. Greenbaum has also served as an adjunct faculty member at Lubin Graduate School of Business, The New School for Social Research and Pace University.
Robert Hannan brings more than 30 years of executive management, marketing and business development experience in the health care industry to the AAD Board of Directors. He started his career in advertising with BBDO and William Esty focusing on the packaged goods industry, then moved to a variety of marketing, management and new venture positions at Glaxo Smith Kline and Becton Dickinson. In 1981, he founded the consulting firm, The Genesis Group, and served as managing partner/CEO until 2000. The firm managed hundreds of strategic management and new business assignments for some of the leading names in the healthcare (diagnostic/molecular device), pharmaceutical and biotech industries. He also founded several widely distributed healthcare publications addressing the business implications of technology innovation (The Genesis Report/Rx, The Genesis Report/Dx, The Genesis Report/MCx, and the Genesis Report Molecular and Genetic Medicine), as well as the strategic management publishing firm POV® Incorporated.
Hannan’s firms were acquired by Wolters Kluwer in 2000, and he served as general manager of this group, then head of the Worldwide Business Intelligence Group until 2002. He now resides in Prince George, SC, and serves as a board member and/or strategic advisor to a number of venture groups and early stage healthcare firms.
A partner in the Raleigh firm, Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan LLP, Mr. Mason has extensive experience representing technology and life sciences companies at all stages of development with particular emphasis on emerging and entrepreneurial enterprises. Prior to joining Smith Anderson, Mr. Mason co-founded Triangle-based Hutchison + Mason in 1996 where his leadership helped the firm grow to 20 lawyers specializing in meeting the general corporate needs of technology and life sciences companies.
Passionate about working with developing entrepreneurs and law students, Mr. Mason has taught as an adjunct instructor at the University of North Carolina’s Kenan-Flagler Business School and the University of North Carolina, School of Law. He is a member of the Board of Directors and the Executive Committee of the Council for Entrepreneurial Development. He is listed, in several publications, among the best lawyers; for example, Business North Carolina’s Legal Elite, Woodward / White’s The Best Lawyers in America and North Carolina Super Lawyers (Business/Corporate). He has authored articles such as “Nobody Said There Would Be Math” and “Valuation of a Start-Up Business – Art Not Science”. Mr. Mason received BA and JD degrees from the University of North Carolina and has been admitted to Practice Law in North Carolina.
Dr. Slenning has a Bachelor's degree in animal science, graduates degrees in agricultural economics and in epidemiology, as well as a DVM, all from the University of California, Davis. That was followed by eight years of private practice in the southern San Joaquin valley—the heart of California’s dairy industry - where he and his partner provide production medicine services to approximately 40,000 dairy cows.
He joined NC State College of Veterinary Medicine in late 1989 where he teaches all four years of veterinary students, undergraduate Animal Science students, and graduate students. He has been the coordinator of the Population Medicine Graduate Program and is currently the head of the Animal Biosecurity Risk Management Group, in the Department of Population Health & Pathobiology. Dr Slenning was also the Associate Editor for the Elsevier journal for Preventive Veterinary Medicine (the flagship journal for veterinary epidemiology and quantitative research) for five years.
Since 2001, Dr. Slenning's focus has been on agricultural disasters with emphases on catastrophic foreign animal disease prevention, detection, and response. He helped form the four-university collaborative 501©(3) organization, the Agriculture Disaster Research Institute, and is currently its Executive Director. He is on several state and regional work groups aiming to improve the resilience of agriculture to disasters of natural, accidental, or intentional origin.
Dr. Slenning has authored 20 peer-reviewed research articles and 87 review/technology transfer papers and presentations on clinical decision theory, economics, epidemiology, agricultural disasters, and foreign animal diseases; 5 book chapters on epidemiology, production medicine, and clinical investigation; a manual for quantifying dairy management quality; and 30 copyrighted spreadsheet applications in all the above areas.
Joseph Wilder, Ph.D., is a Research Professor in the Rutgers University Center for Advanced Information Processing (CAIP). Currently, he is pursuing research in pattern recognition and machine vision. He has contributed to the design and development of the current Rutgers multi-modal human-computer interface in the areas of gaze tracking, face tracking and speech and gaze interactions. He brings his knowledge of the image processing and pattern recognition aspects of the analysis of multiple wavelength fluorescence fields to the Scientific Advisory Board. Dr. Wilder received his Ph.D. in Electrical Engineering from the University of Pennsylvania. He has published papers on pattern recognition, human visual search and decision-making, and applications of machine vision to industrial and biomedical inspection, measurement and guidance. Dr. Wilder holds 12 U.S. patents related to these research areas.
Mr. Adler recently retired after a 47-year career in the investment industry. His experience encompasses service as an investment strategist and manager of both equity and fixed-income portfolios on behalf of major European financial institutions. As Vice President and Senior Investment Officer, he established and managed Portfolio Management Departments for the US affiliates of two large German banking institutions. Earlier, he had investment banking and security analysis experience with eminent American securities firms. Mr. Adler served on the Boards of Directors of The Greenfield Fund, an SEC-registered mutual fund, and Asia Electronics Holdings Co., a China-based manufacturer of electronic components that was listed on NASDAQ. Mr. Adler has a BA degree from Swarthmore College and has done graduate work at the NYU Graduate School of Business Administration. He is a member of the CFA Institute and the New York Society of Security Analysis and a retired member of the New York Association of Business Economists.
Mr. Appert has for the past twelve years been an independent consultant in the areas of financial and turnaround management and strategic planning for small to medium sized companies. For the previous eighteen years, he held various executive positions with administrative, financial and Information processing responsibilities in the domestic and overseas operations of Becton Dickinson and Company. Before that he was for ten years an executive with Ernst and Young, LLP. He is a retired CPA and holder of the CCP certification in information processing. He is also a member of the Financial Executives International and several other professional societies. Mr. Appert is a graduate of Fordham University with an A.B. in Mathematics, Columbia University Business School with an MBA in both Accounting and Finance, and the PMD Executive Program at the Harvard Business School.